The A@#hole Scientist

Can a vexing sense of entitlement actually aid in the pursuit of knowledge?

Written byAaron James
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

DOUBLEDAY, OCTOBER 2012The mechanical engineer Thomas Midgley (1889–1944) did some pretty unsavory deeds with the help of his scientific reputation. If his promotion of climate-changing CFCs was an honest mistake, the same cannot be said of his brazen advancement of “anti-knock” lead additives. Midgely arguably knew there was compelling evidence that auto workers were suffering dearly from exposure to the neurotoxins. Yet he offered misleading public demonstrations of their supposed safety anyway, knowingly exploiting the public’s trust in science for personal profit.

Midgley qualifies as an “asshole” according to one definition of the term. An asshole (henceforth abbreviated “a-hole”) is a guy (or gal) who allows himself special advantages in social relationships out of an entrenched (and mistaken) sense of entitlement that immunizes him against the complaints of other people. In my latest book, Assholes: A Theory, I develop this definition, along with the pros and cons of this distinctive kind of vice.

While Midgley failed his obligations as a scientist to society at large, scientists are often a-holes to each other. Well-known examples include Edward Teller’s famous machinations against J. Robert Oppenheimer, or Thomas Edison’s proprietary manipulations against Nikola Tesla. There is also a plethora of workaday a-hole moves such as: denying funding to one’s competitors, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies